On July 31, 2025, the White House released a fact sheet [1] discussing additional steps taken by the Trump administration surrounding efforts towards lowering drug prices for Americans. The fact sheet was a follow-up to Executive Order (EO) 14297 signed ...

Manufacturers that participate in the MDRP must report certain drug-related product and pricing information on a one-time, monthly, and/or quarterly basis to CMS. This information is used, in turn, to operate the program. It includes the classification of a manufacturer's drug as a brand-name or generic drug. This classification helps to determine the rebates that manufacturers pay to the ...

In his push to “lower prescription drug prices for all Americans,” President Donald Trump is calling on three specific actions in his Great American Healthcare Plan, released January 15.

BOLSTERING PHARMACEUTICAL SECURITY: Today, President Donald J. Trump signed an Executive Order to fill the Strategic Active Pharmaceutical Ingredients Reserve (SAPIR) with critical drug components, ensuring a resilient domestic supply chain for essential ...

Este artículo estará disponible en español en El Tiempo Latino. In signing an executive order aimed at reducing U.S. drug prices, President Donald Trump said some prices would be cut in half or more “almost immediately.” But the order is light on ...